Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 3, 2006, Pages 327-335

  Patel, Nick C ^a,c   DelBello, Melissa P ^a   Kowatch, Robert A ^b   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; PLACEBO; QUETIAPINE; VALPROATE SEMISODIUM;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; CHILD PSYCHIATRY; CHILDREN DEPRESSION RATING SCALE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCORING SYSTEM; SYMPTOM; VALIDATION PROCESS;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DEPRESSION; DIBENZOTHIAZEPINES; HUMANS; LITHIUM CARBONATE; PSYCHIATRIC STATUS RATING SCALES; VALPROIC ACID;

EID: 33745134699     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.327     Document Type: Article

References (21)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Wahsington (DC), American Psychiatric Association, 1994.
2. Baldassano CF: Assessment tools for screening and monitoring bipolar disorder. Bipolar Disord 7(Suppl 1):8-15, 2005.
3. Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA: Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: Report of a consensus conference. J Child Adolesc Psychopharmacol 13:1-15, 2003.
4. Cohen L: Statistical Power Analysis for the Behavioral Sciences. Hillsdale (New Jersey), Erlbaum, 1988.
5. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002.
6. DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM: Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disord 3:53-57, 2001.
7. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002.
8. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901, 2003.
9. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR: Double-blind, 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409-417, 2005.
10. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851-855, 1991.
11. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM: A prospective, open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250, 2001.
12. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo C: Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 40:450-455, 2001.
13. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62, 1960.
14. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM: Lithium treatment of acute mania in adolescents: A large, open trial. J Am Acad Child Adolesc Psychiatry 42:1038-1045, 2003.
15. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JM: Lithium treatment of acute mania in adolescents: A placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 43:984-993, 2004.
16. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG: Open-label, prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82S:S103-S111, 2004.
17. Poznanski E, Mokros H: Children's Depression Rating Scale-Revised. Los Angeles (California), Western Psychological Services, 1995.
18. Saxena K, Howe M, Chang K: Lamotrigine adjunct or monotherapy for adolescent bipolar depression or mixed mania, [abstract] Atlanta (Georgia), American Psychiatric Association, 158th Annual Meeting, May 21-26, 2005.
19. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP Psychiatry Res 73:159-171, 1997.
20. Tillman R, Geller B: A brief screening tool for a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 162:1214-1216, 2005.
21. Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller RA, Bowden C: An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 41:1224-1230, 2002.